[Vardenafil: long-term and continuous treatment of severe erectile disorders].
Two cases are analysed to show possibility of severe erectile dysfunction (ED) treatment with long-term and regular intake of phosphodilesterase-5 (PDE-5) vardenaphil. A 39-year-old patient had cavernous fibrosis due to intracavernous introduction of vasoactive medication. Vardenafil was taken in a dose 20 mg in the evening for 6 months. At control examination ED relieved to a mild degree. Further intake of vardenaphil on demand is recommended. The other man 22 years of age had a severe erectile dysfunction after hip bones fracture and subsequent reconstruction of the urethra. He received vardenafil in a dose 10 mg in the evening for 3 months. After the treatment ED improved to a mild degree and further on-demand intake is recommended.
Aliaev
Iu G
IuG
Vinarov
A Z
AZ
Akhvlediani
N D
ND
D000328:Adult; D007172:Erectile Dysfunction / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D013450:Sulfones / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014227:Triazines / Q000008:administration & dosage / Q000627:therapeutic use; D014463:Ultrasonography; D000069058:Vardenafil Dihydrochloride
D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D013450:Sulfones; D014227:Triazines; D000069058:Vardenafil Dihydrochloride